Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

A visual rating scale for cingulate island sign on 18F-FDG-PET to differentiate dementia with Lewy bodies and Alzheimer's disease

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Lemierre's syndrome with stroke and stenosis of the internal carotid artery suggesting focal vasculitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Predictive role of presenting symptoms and clinical findings in idiopathic intracranial hypertension

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Beneficial effect of intravenous immunoglobulin treatment in a patient with antiphospholipid syndrome associated chorea

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Global brain atrophy and metabolic dysfunction in LGI1 encephalitis: A prospective multimodal MRI study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Normal pressure hydrocephalus secondary to Lyme disease, a case report and review of seven reported cases

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Epigenetic modulation of AREL1 and increased HLA expression in brains of multiple system atrophy patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Valid diagnosis of dementia with Lewy bodies (DLB) is essential to establish appropriate treatment and care. However, the diagnostic accuracy is complicated by clinical and pathological overlap with Alzheimer's disease (AD). Cingulate island sign (CIS), defined as sparing of posterior cingulate cortex (PCC) relative to precuneus and cuneus on 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET), is included in the revised diagnostic DLB criteria. There are no guidelines for the visual grading of CIS, although visual rating is a fast-applicable method in a clinical setting. The objective was to develop a robust visual CIS scale and evaluate the performance in differentiating DLB with and without amyloid beta pathology (Aβ+/-), and AD. 18F-FDG-PET scans from 35 DLB patients, 36 AD patients, and 23 healthy controls were rated according to a visual CIS scale based on specific reading criteria. The visual CIS scale was validated against a quantitative CIS ratio derived from a region of interest analysis of PCC, precuneus, and cuneus. DLB patients had a significantly higher visual CIS score compared to AD patients, and controls. A cut-off visual CIS score of 4 significantly differentiated DLB Aβ- patients from DLB Aβ+ patients. In conclusion, the visual CIS scale is clinically useful to differentiate DLB from AD. The degree of CIS may be related to Aβ pathology in DLB patients.

OriginalsprogEngelsk
TidsskriftJournal of the Neurological Sciences
Vol/bind410
Sider (fra-til)116645
Antal sider10
ISSN0022-510X
DOI
StatusUdgivet - 15 mar. 2020

Bibliografisk note

Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

ID: 59212009